Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Healthcare Biotechnology Medical Instruments & Supplies
Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Breakthrough Device Designation
View:
Post by TechOne on Feb 05, 2024 3:23pm

Breakthrough Device Designation

2024 is the year for Spectral ..  Long Overdue.. Get it done.. Hopefully a succesful outcome.. 

This designation is now  18 months or so.. July 11, 2022 

https://spectraldx.com/fda-grants-spectral-breakthrough-device-designation-for-toraymyxin-pmx/
Comment by ChesterLives on Feb 05, 2024 3:37pm
Great read for all the newbies to Spectral. There is an ironclad foundation to this trial and this is worth a re read or especially a read for the first time.
Comment by gebremeskel on Feb 05, 2024 4:12pm
It's starting to feel like Sept. 2016 around here with all the positivity and expectation of success. But this time around it looks like it's really going to happen. I hope a lot of longs are still around for a long delayed redemption.
Comment by ChesterLives on Feb 05, 2024 4:38pm
I would argue that it hasn't even started yet. The volume has yet to come into play... but it will, very soon!
Spectral Medical Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities